A Multicenter, Active and Placebo-controlled Study of Enteric Coated Sevelamer in Patients With Mild to Moderate Hypercholesteremia

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2008
A total of 120 patients will be entered in this study to assess the safety and efficacy of enteric coated sevelamer (ECS) to lower LDL cholesterol. Patients will be randomized into two active treatment groups, two placebo groups and one active control group.
Epistemonikos ID: 2937b4ff4f7873cf1430baffbbccb16b8d81f1f0
First added on: May 05, 2024